Startseite Neonatal hypoglycaemia in the offsprings of parents with maturity-onset diabetes of the young (MODY)
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Neonatal hypoglycaemia in the offsprings of parents with maturity-onset diabetes of the young (MODY)

  • Jakub Maly ORCID logo EMAIL logo , Jana Urbanova , Vladimir Musil , Jan Broz , Milos Cerny und Ludmila Brunerova
Veröffentlicht/Copyright: 28. April 2025

Abstract

Introduction

Neonatal hypoglycaemia is the most common metabolic disorder of various causes, relatively rare being MODY (Maturity Onset Diabetes of the Young).

Content

Data search of relevant articles focused on hypoglycaemia in carriers of selected MODY gene mutations published from 2007 to 2022 was performed in databases Medline, PubMed, Cochrane and UptoDate based on key words: ‘hyperinsulinemic hypoglycaemia’, ‘congenital hyperinsulinism’, ‘MODY’, ‘HNF4A mutation’, ‘HNF1A mutation’.

Summary

Loss of function of HNF4A and HNF1A genes comprises approximately to 5.9 % of diazoxide responsive hyperinsulinemic hypoglycaemia, which may appear in 15 % HNF4A mutation carriers. A typical finding of HNF4A mutation carriers with neonatal hypoglycaemia was a birth weight above 4000 g or above 97th percentile.

Outlook

Although mutations in MODY genes represent a rare cause of neonatal hypoglycaemia, they should be considered in the differential diagnosis, particularly in cases of persistent hypoglycaemia requiring intensive care.


Corresponding author: Jakub Maly, Department of Children and Adolescents, Faculty Hospital Kralovske Vinohrady, Srobarova 50, 100 34, Praha, Czechia; and Third Faculty of Medicine, Charles University, Prague, Czechia, E-mail:

  1. Research ethics: Not applicable.

  2. Informed consent: Not applicable.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Adamkin, DH. Neonatal hypoglycaemia. Semin Fetal Neonatal Med 2017;22:36–41. https://doi.org/10.1016/j.siny.2016.08.007.Suche in Google Scholar PubMed

2. Thornton, PS, Stanley, CA, De Leon, DD, Harris, D, Haymond, MW, Hussain, K, et al.. Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr 2015;167:238–45. https://doi.org/10.1016/j.jpeds.2015.03.057.Suche in Google Scholar PubMed PubMed Central

3. Gevers, EF, Fisher, DA, Dattani, MT. Fetal and neonatal endocrinology. In: Jameson, JL, De Groot, LJ, editors. Endocrinology: adult and pediatric, 7th ed. Saunders; 2016:2499–529.e9 pp.10.1016/B978-0-323-18907-1.00145-1Suche in Google Scholar

4. Rozenkova, K, Malikova, J, Nessa, A, Dusatkova, L, Bjorkhaug, L, Obermannova, B, et al.. High incidence of heterozygous ABCC8 and HNF1A mutations in Czech patients with congenital hyperinsulinism. J Clin Endocrinol Metab 2015;100:E1540–9. https://doi.org/10.1210/jc.2015-2763.Suche in Google Scholar PubMed

5. Rahman, SA, Nessa, A, Hussain, K. Molecular mechanisms of congenital hyperinsulinism. J Mol Endocrinol 2015;54:R119–29. https://doi.org/10.1530/JME-15-0016.Suche in Google Scholar PubMed

6. Marquard, J, Palladino, AA, Stanley, CA, Mayatepek, E, Meissner, T. Rare forms of congenital hyperinsulinism. Semin Pediatr Surg 2011;20:38–44. https://doi.org/10.1053/j.sempedsurg.2010.10.006.Suche in Google Scholar PubMed

7. Hewat, TI, Yau, D, Jerome, JCS, Laver, TW, Houghton, JAL, Shields, BM, et al.. Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11. Eur J Endocrinol 2021;185:813–18. https://doi.org/10.1530/EJE-21-0476.Suche in Google Scholar PubMed PubMed Central

8. McGlacken-Byrne, SM, Hawkes, CP, Flanagan, SE, Ellard, S, McDonnell, CM, Murphy, NP. The evolving course of HNF4A hyperinsulinaemic hypoglycaemia--a case series. Diabet Med 2014;31:e1–5. https://doi.org/10.1111/dme.12259.Suche in Google Scholar PubMed

9. Colclough, K, Bellanne-Chantelot, C, Saint-Martin, C, Flanagan, SE, Ellard, S. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia. Hum Mutat 2013;34:669–85. https://doi.org/10.1002/humu.22279.Suche in Google Scholar PubMed

10. Caironi, V, Schwitzgebel, VM, Jornayvaz, FR, Gariani, K. MODY type diabetes: an often-misunderstood entity. Rev Med Suisse 2021;17:1062–6. https://doi.org/10.53738/REVMED.2021.17.741.1062.Suche in Google Scholar

11. Urbanova, J, Brunerova, L, Broz, J. Hypoglycemia and antihyperglycemic treatment in adult MODY patients – a systematic review of literature. Diabetes Res Clin Pract 2019;158:107914. https://doi.org/10.1016/j.diabres.2019.107914.Suche in Google Scholar PubMed

12. Urbanova, J, Brunerova, L, Nunes, M, Broz, J. Identification of MODY among patients screened for gestational diabetes: a clinician’s guide. Arch Gynecol Obstet 2020;302:305–14. https://doi.org/10.1007/s00404-020-05626-y.Suche in Google Scholar PubMed

13. Urbanova, J, Brunerova, L, Broz, J. Hidden MODY-looking for a needle in a haystack. Front Endocrinol 2018;9:355. https://doi.org/10.3389/fendo.2018.00355.Suche in Google Scholar PubMed PubMed Central

14. Brunerova, L, Rahelic, D, Ceriello, A, Broz, J. Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young: a mini review. Diabetes Metab Res Rev 2018;34:e2940. https://doi.org/10.1002/dmrr.2940.Suche in Google Scholar PubMed

15. Pearson, ER, Boj, SF, Steele, AM, Barrett, T, Stals, K, Shield, JP, et al.. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 2007;4:e118. https://doi.org/10.1371/journal.pmed.0040118.Suche in Google Scholar PubMed PubMed Central

16. Flanagan, SE, Kapoor, RR, Mali, G, Cody, D, Murphy, N, Schwahn, B, et al.. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol 2010;162:987–92. https://doi.org/10.1530/EJE-09-0861.Suche in Google Scholar PubMed PubMed Central

17. Tung, JY, Boodhansingh, K, Stanley, CA, De Leon, DD. Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations. Pediatr Diabetes 2018;19:910–16. https://doi.org/10.1111/pedi.12655.Suche in Google Scholar PubMed PubMed Central

18. McGlacken-Byrne, SM, Mohammad, JK, Conlon, N, Gubaeva, D, Siersbaek, J, Schou, AJ, et al.. Clinical and genetic heterogeneity of HNF4A/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia. Eur J Endocrinol 2022;186:417–27. https://doi.org/10.1530/EJE-21-0897.Suche in Google Scholar PubMed

19. Kapoor, RR, Locke, J, Colclough, K, Wales, J, Conn, JJ, Hattersley, AT, et al.. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes 2008;57:1659–63. https://doi.org/10.2337/db07-1657.Suche in Google Scholar PubMed

20. Dusatkova, P, Pruhova, S, Sumnik, Z, Kolouskova, S, Obermannova, B, Cinek, O, et al.. HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes. J Pediatr Endocrinol Metab 2011;24:187–9. https://doi.org/10.1515/jpem.2011.083.Suche in Google Scholar PubMed

21. Stanescu, DE, Hughes, N, Kaplan, B, Stanley, CA, De Leon, DD. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab 2012;97:E2026–30. https://doi.org/10.1210/jc.2012-1356.Suche in Google Scholar PubMed PubMed Central

22. Huerta-Saenz, L, Saunders, C, Yan, Y (2018) Challenging diagnosis of congenital hyperinsulinism in two infants of diabetic mothers with rare pathogenic KCNJ11 and HNF4A gene variants. Int J Pediatr Endocrinol 2018;5. https://doi.org/10.1186/s13633-018-0060-7.Suche in Google Scholar PubMed PubMed Central

23. Vlachopapadopoulou, EA, Dikaiakou, E, Fotiadou, A, Sifianou, P, Tatsi, EB, Sertedaki, A, et al.. Detection of hepatocyte nuclear factor 4A(HNF4A) gene variant as the cause for congenital hyperinsulinism leads to revision of the diagnosis of the mother. J Pediatr Endocrinol Metab 2021;34:527–30. https://doi.org/10.1515/jpem-2020-0302.Suche in Google Scholar PubMed

24. Yau, D, Colclough, K, Natarajan, A, Parikh, R, Canham, N, Didi, M, et al.. Congenital hyperinsulinism due to mutations in HNF1A. Eur J Med Genet 2020;63:103928. https://doi.org/10.1016/j.ejmg.2020.103928.Suche in Google Scholar PubMed

25. Cromer, SJ, Sella, AC, Rosenberg, E, Scully, K, McDonnell, M, Abreu, AP, et al.. Report of prolonged neonatal hypoglycemia in three infants of mothers with variants in HNF1A. AACE Clin Case Rep 2022;8:224–30. https://doi.org/10.1016/j.aace.2022.07.004.Suche in Google Scholar PubMed PubMed Central

26. Lord, K, De Leon, DD. Hyperinsulinism in the neonate. Clin Perinatol 2018;45:61–74. https://doi.org/10.1016/j.clp.2017.10.007.Suche in Google Scholar PubMed

Received: 2025-01-19
Accepted: 2025-03-30
Published Online: 2025-04-28
Published in Print: 2025-06-26

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Reviews
  3. Pubertal disorders in juvenile idiopathic arthritis: a systemic review
  4. Hormonal therapy for impaired growth due to pediatric-onset inflammatory bowel disease: a systematic review and meta-analysis with trial sequential analysis
  5. Mini Review
  6. Neonatal hypoglycaemia in the offsprings of parents with maturity-onset diabetes of the young (MODY)
  7. Original Articles
  8. Cord blood metabolomic profiling in high risk newborns born to diabetic, obese, and overweight mothers: preliminary report
  9. Impact of Covid-19 on children and adolescents with type 1 diabetes: lifestyle, telecommunication service, and quality of life
  10. The diagnostic utility of bioelectrical impedance analysis in distinguishing precocious puberty from premature thelarche
  11. Infant gonadotropins predict spontaneous puberty in girls with Turner syndrome
  12. Bioinformatics analysis explores key pathways and hub genes in central precocious puberty
  13. Impact of growth hormone therapy on bone and body composition in prepubertal children with idiopathic short stature
  14. Presence of hyperandrogenemia in cases evaluated due to menstrual irregularity, the effect of clinical and/or biochemical hyperandrogenemia on polycystic ovary syndrome
  15. Cardiac function in children with congenital adrenal hyperplasia
  16. Short Communication
  17. Clinical and genetic insights into congenital lipoid adrenal hyperplasia: a case series from a tertiary care center in North India
  18. Case Reports
  19. Two families, two pathways: a case series of 46, XY DSD with 17α-hydroxylase deficiency and isolated 17,20-lyase deficiency due to novel CYB5A variant
  20. Coexistence of SRY, DHX37 and POR gene variants in a patient with 46,XY disorder of sex development
  21. Diabetes, macrocytosis, and skin changes in large-scale mtDNA deletion
Heruntergeladen am 3.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2025-0042/html
Button zum nach oben scrollen